Skip to main content
. Author manuscript; available in PMC: 2013 Oct 10.
Published in final edited form as: J Neurooncol. 2012 Feb 23;108(1):179–185. doi: 10.1007/s11060-012-0828-1

Fig. 3.

Fig. 3

a Targeting of atypical meningioma. Axial SPGR MRI sequence with radiosurgical dose targeting enhancing tumor. The yellow line represents the 50% isodose line. The red line represents tumor delineation. b, c Follow-up MRI demonstrating marginal recurrence. b An axial SPGR MRI sequence. c Sagittal SPGR MRI sequence